Value offered by therapy options in breast cancer

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.491, 2005-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fulvestrant extends hormonal therapy options in breast cancer

Inpharma, Vol. 1, Iss. 1473, 2005-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Therapeutic options for metastatic breast cancer

By Morris Patrick G McArthur Heather L Hudis Clifford A

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 967-981

Informa Healthcare

Access to resources Recommend Favorite

Endocrine Therapy of Breast Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapy of Breast Cancer

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 497-517

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammatory breast cancer: what are the treatment options?

By Iniesta Maria D Mooney Colin J Merajver Sofia D

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 2987-2997

Informa Healthcare

Access to resources Recommend Favorite